Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Rutherrin

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Apr 17, 2022 11:35am

181 Views

Post# 34608390

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin

Hi CS yes agreed and actually quite confident in the NMIBC Trial on the basis that if we didn`t have the goods Dr.Vera would not have come on board. It`s the Blue Sky stuff (treatment of non-superficial tumours) that has gone significantly awry.

Everything was suggestive of this happening - until it didn`t. Maybe I`m over-stating the potential impact of TLT announcing a successful non-invasive treatment for lung cancer (although sadly and mysteriously no longer a prospect for GBM) but it would certainly wake me up with my morning coffee.

Happy Easter to you and fellow Contributors.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China